| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF6 MYH8 LIMCH1 CTTNBP2 DST NEB ARHGEF10 JAKMIP2 CLIP1 TLN1 SYNE2 | 7.05e-06 | 1099 | 40 | 11 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | 3.55e-04 | 479 | 40 | 6 | GO:0003779 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 8.81e-04 | 22 | 40 | 2 | GO:0051010 | |
| GeneOntologyMolecularFunction | microtubule binding | 3.28e-03 | 308 | 40 | 4 | GO:0008017 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 3.35e-03 | 43 | 40 | 2 | GO:0008307 | |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 4.00e-03 | 47 | 40 | 2 | GO:0051539 | |
| GeneOntologyCellularComponent | sarcomere | 8.39e-05 | 249 | 38 | 5 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 1.29e-04 | 273 | 38 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | Z disc | 1.60e-04 | 151 | 38 | 4 | GO:0030018 | |
| GeneOntologyCellularComponent | myosin complex | 1.68e-04 | 59 | 38 | 3 | GO:0016459 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.71e-04 | 290 | 38 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | I band | 2.29e-04 | 166 | 38 | 4 | GO:0031674 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 5.56e-04 | 576 | 38 | 6 | GO:0015629 | |
| GeneOntologyCellularComponent | spliceosomal complex | 6.11e-04 | 215 | 38 | 4 | GO:0005681 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 7.26e-04 | 97 | 38 | 3 | GO:0071013 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 7.26e-04 | 97 | 38 | 3 | GO:0005684 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.07e-03 | 1179 | 38 | 8 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.12e-03 | 1187 | 38 | 8 | GO:0099081 | |
| GeneOntologyCellularComponent | microtubule plus-end | 1.18e-03 | 28 | 38 | 2 | GO:0035371 | |
| GeneOntologyCellularComponent | myosin II complex | 1.18e-03 | 28 | 38 | 2 | GO:0016460 | |
| GeneOntologyCellularComponent | nuclear matrix | 2.09e-03 | 140 | 38 | 3 | GO:0016363 | |
| GeneOntologyCellularComponent | microtubule end | 2.17e-03 | 38 | 38 | 2 | GO:1990752 | |
| GeneOntologyCellularComponent | nuclear periphery | 3.68e-03 | 171 | 38 | 3 | GO:0034399 | |
| Domain | GRIP_dom | 2.49e-04 | 12 | 37 | 2 | IPR000237 | |
| Domain | GRIP | 2.49e-04 | 12 | 37 | 2 | PS50913 | |
| Domain | CH | 2.87e-04 | 65 | 37 | 3 | SM00033 | |
| Domain | CH | 3.58e-04 | 70 | 37 | 3 | PF00307 | |
| Domain | - | 3.73e-04 | 71 | 37 | 3 | 1.10.418.10 | |
| Domain | CH | 4.05e-04 | 73 | 37 | 3 | PS50021 | |
| Domain | CH-domain | 4.38e-04 | 75 | 37 | 3 | IPR001715 | |
| Domain | Actinin_actin-bd_CS | 9.41e-04 | 23 | 37 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 9.41e-04 | 23 | 37 | 2 | PS00020 | |
| Domain | ACTININ_1 | 9.41e-04 | 23 | 37 | 2 | PS00019 | |
| Domain | Spectrin | 9.41e-04 | 23 | 37 | 2 | PF00435 | |
| Domain | Spectrin_repeat | 1.50e-03 | 29 | 37 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 1.82e-03 | 32 | 37 | 2 | IPR018159 | |
| Domain | SPEC | 1.82e-03 | 32 | 37 | 2 | SM00150 | |
| Domain | ZnF_C2HC | 5.31e-03 | 55 | 37 | 2 | SM00343 | |
| Domain | Znf_CCHC | 5.31e-03 | 55 | 37 | 2 | IPR001878 | |
| Pubmed | 6.78e-09 | 497 | 42 | 9 | 23414517 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 8.18e-09 | 123 | 42 | 6 | 26912792 | |
| Pubmed | LIMCH1 CTTNBP2 SNW1 DST JAKMIP2 TRIP11 CLIP1 GOLGA4 GOLGB1 SYNE2 NAT10 | 1.35e-08 | 963 | 42 | 11 | 28671696 | |
| Pubmed | SLU7 BPTF CCT2 SNW1 RESF1 PPAT LIN9 SMC1A RAB3GAP2 TLN1 SF3B6 | 5.40e-08 | 1103 | 42 | 11 | 34189442 | |
| Pubmed | 1.13e-07 | 191 | 42 | 6 | 31177093 | ||
| Pubmed | SLU7 FAM184A SNW1 ARHGEF10 GOLGA4 GOLGB1 RAB3GAP2 TLN1 SF3B6 SYNE2 NAT10 NOC3L | 1.20e-07 | 1487 | 42 | 12 | 33957083 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 2.93e-07 | 1024 | 42 | 10 | 24711643 | |
| Pubmed | 2.96e-07 | 225 | 42 | 6 | 12168954 | ||
| Pubmed | 7.17e-07 | 1429 | 42 | 11 | 35140242 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | LIMCH1 DST RESF1 ARHGEF10 TRIP11 GOLGA4 GOLGB1 RAB3GAP2 SYNE2 | 7.18e-07 | 861 | 42 | 9 | 36931259 |
| Pubmed | 9.95e-07 | 653 | 42 | 8 | 22586326 | ||
| Pubmed | 1.42e-06 | 2 | 42 | 2 | 34415548 | ||
| Pubmed | 2.38e-06 | 322 | 42 | 6 | 26514267 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.84e-06 | 332 | 42 | 6 | 32786267 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 3.62e-06 | 1353 | 42 | 10 | 29467282 | |
| Pubmed | 4.52e-06 | 360 | 42 | 6 | 33111431 | ||
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 4.75e-06 | 92 | 42 | 4 | 15840729 | |
| Pubmed | 4.91e-06 | 568 | 42 | 7 | 37774976 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 5.76e-06 | 582 | 42 | 7 | 20467437 | |
| Pubmed | 6.36e-06 | 1442 | 42 | 10 | 35575683 | ||
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | 1.07e-05 | 419 | 42 | 6 | 28700943 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.38e-05 | 934 | 42 | 8 | 33916271 | |
| Pubmed | 1.42e-05 | 5 | 42 | 2 | 26506308 | ||
| Pubmed | 2.04e-05 | 708 | 42 | 7 | 39231216 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 2.53e-05 | 289 | 42 | 5 | 23752268 | |
| Pubmed | 2.71e-05 | 494 | 42 | 6 | 26831064 | ||
| Pubmed | 3.03e-05 | 504 | 42 | 6 | 34432599 | ||
| Pubmed | 3.05e-05 | 754 | 42 | 7 | 35906200 | ||
| Pubmed | Skeletal muscle phenotypes initiated by ectopic MyoD in transgenic mouse heart. | 3.97e-05 | 8 | 42 | 2 | 1618148 | |
| Pubmed | 4.11e-05 | 55 | 42 | 3 | 18570454 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 4.16e-05 | 1425 | 42 | 9 | 30948266 | |
| Pubmed | 4.87e-05 | 549 | 42 | 6 | 38280479 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 4.98e-05 | 167 | 42 | 4 | 20362541 | |
| Pubmed | 5.40e-05 | 339 | 42 | 5 | 30415952 | ||
| Pubmed | 5.40e-05 | 339 | 42 | 5 | 37232246 | ||
| Pubmed | Expression QTL and regulatory network analysis of microtubule-associated protein tau gene. | 7.78e-05 | 11 | 42 | 2 | 19233709 | |
| Pubmed | SVEP1 is an endogenous ligand for the orphan receptor PEAR1. | 7.78e-05 | 11 | 42 | 2 | 36792666 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 8.33e-05 | 605 | 42 | 6 | 28977666 | |
| Pubmed | 1.25e-04 | 652 | 42 | 6 | 31180492 | ||
| Pubmed | 1.28e-04 | 14 | 42 | 2 | 12509440 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.33e-04 | 954 | 42 | 7 | 36373674 | |
| Pubmed | 1.44e-04 | 418 | 42 | 5 | 34709266 | ||
| Pubmed | 1.50e-04 | 222 | 42 | 4 | 37071664 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.67e-04 | 989 | 42 | 7 | 36424410 | |
| Pubmed | A genome-wide association study of brain lesion distribution in multiple sclerosis. | 1.69e-04 | 16 | 42 | 2 | 23412934 | |
| Pubmed | 1.83e-04 | 234 | 42 | 4 | 36243803 | ||
| Pubmed | 1.91e-04 | 17 | 42 | 2 | 34622152 | ||
| Pubmed | 2.19e-04 | 723 | 42 | 6 | 34133714 | ||
| Pubmed | 2.30e-04 | 98 | 42 | 3 | 34943047 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 2.53e-04 | 1415 | 42 | 8 | 28515276 | |
| Pubmed | 2.53e-04 | 472 | 42 | 5 | 38943005 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 2.58e-04 | 256 | 42 | 4 | 33397691 | |
| Pubmed | 2.67e-04 | 20 | 42 | 2 | 21689717 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 2.84e-04 | 759 | 42 | 6 | 35915203 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 3.05e-04 | 1455 | 42 | 8 | 22863883 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 3.20e-04 | 271 | 42 | 4 | 32433965 | |
| Pubmed | 3.22e-04 | 777 | 42 | 6 | 35844135 | ||
| Pubmed | 3.24e-04 | 272 | 42 | 4 | 31010829 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 3.24e-04 | 498 | 42 | 5 | 36634849 | |
| Pubmed | 3.32e-04 | 111 | 42 | 3 | 12508121 | ||
| Pubmed | 3.43e-04 | 786 | 42 | 6 | 29128334 | ||
| Pubmed | 3.49e-04 | 506 | 42 | 5 | 30890647 | ||
| Pubmed | 3.54e-04 | 23 | 42 | 2 | 22792062 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 3.68e-04 | 1496 | 42 | 8 | 32877691 | |
| Pubmed | 3.69e-04 | 1497 | 42 | 8 | 31527615 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.77e-04 | 283 | 42 | 4 | 30585729 | |
| Pubmed | 3.86e-04 | 24 | 42 | 2 | 19616115 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 4.27e-04 | 1155 | 42 | 7 | 20360068 | |
| Pubmed | Interactome of the negative regulator of nuclear import BRCA1-binding protein 2. | 4.54e-04 | 26 | 42 | 2 | 25820252 | |
| Pubmed | 4.90e-04 | 27 | 42 | 2 | 35147267 | ||
| Pubmed | 5.00e-04 | 844 | 42 | 6 | 25963833 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 5.09e-04 | 847 | 42 | 6 | 35235311 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 5.27e-04 | 130 | 42 | 3 | 35545047 | |
| Pubmed | Maternal DNA Methylation Regulates Early Trophoblast Development. | 5.28e-04 | 28 | 42 | 2 | 26812015 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 5.75e-04 | 134 | 42 | 3 | 25452129 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 5.76e-04 | 565 | 42 | 5 | 25468996 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 6.63e-04 | 583 | 42 | 5 | 29844126 | |
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 6.90e-04 | 32 | 42 | 2 | 22424883 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 7.06e-04 | 1257 | 42 | 7 | 36526897 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.58e-04 | 341 | 42 | 4 | 32971831 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 7.68e-04 | 148 | 42 | 3 | 32538781 | |
| Pubmed | 7.83e-04 | 149 | 42 | 3 | 25184681 | ||
| Pubmed | 8.13e-04 | 151 | 42 | 3 | 17043677 | ||
| Pubmed | 8.26e-04 | 35 | 42 | 2 | 28106071 | ||
| Pubmed | 8.26e-04 | 35 | 42 | 2 | 22337587 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 9.21e-04 | 949 | 42 | 6 | 36574265 | |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 9.23e-04 | 37 | 42 | 2 | 27565344 | |
| Pubmed | 9.65e-04 | 634 | 42 | 5 | 34591612 | ||
| Pubmed | 9.93e-04 | 638 | 42 | 5 | 31182584 | ||
| Pubmed | Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice. | 1.03e-03 | 39 | 42 | 2 | 24703692 | |
| Pubmed | 1.13e-03 | 169 | 42 | 3 | 23665500 | ||
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 1.15e-03 | 170 | 42 | 3 | 16159877 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 1.15e-03 | 1367 | 42 | 7 | 32687490 | |
| Pubmed | 1.17e-03 | 1371 | 42 | 7 | 36244648 | ||
| Interaction | CEBPA interactions | SLU7 BPTF CCT2 SNW1 RESF1 PPAT LIN9 SMC1A RAB3GAP2 TLN1 SF3B6 NAT10 | 5.73e-06 | 1245 | 42 | 12 | int:CEBPA |
| Interaction | CUL7 interactions | 6.91e-06 | 845 | 42 | 10 | int:CUL7 | |
| Interaction | HDAC1 interactions | BPTF CCT2 MYH8 DST LIN9 GOLGA4 SMC1A GOLGB1 RAB3GAP2 TLN1 SYNE2 | 1.17e-05 | 1108 | 42 | 11 | int:HDAC1 |
| Interaction | SF3A2 interactions | 2.04e-05 | 273 | 42 | 6 | int:SF3A2 | |
| Interaction | NUP43 interactions | 3.80e-05 | 625 | 42 | 8 | int:NUP43 | |
| Interaction | CDC5L interactions | 5.39e-05 | 855 | 42 | 9 | int:CDC5L | |
| Interaction | MECOM interactions | 9.21e-05 | 358 | 42 | 6 | int:MECOM | |
| Interaction | CHD4 interactions | 1.10e-04 | 938 | 42 | 9 | int:CHD4 | |
| Interaction | MYBPC2 interactions | 1.12e-04 | 45 | 42 | 3 | int:MYBPC2 | |
| Interaction | GBP7 interactions | 1.18e-04 | 8 | 42 | 2 | int:GBP7 | |
| Interaction | B3GAT1 interactions | 1.22e-04 | 377 | 42 | 6 | int:B3GAT1 | |
| Interaction | CLIP4 interactions | 1.28e-04 | 47 | 42 | 3 | int:CLIP4 | |
| Interaction | SIRT7 interactions | 1.29e-04 | 744 | 42 | 8 | int:SIRT7 | |
| Interaction | EED interactions | BPTF CCT2 LIMCH1 CLIP1 LIN9 SMC1A RAB3GAP2 TLN1 SF3B6 NAT10 NOC3L | 1.33e-04 | 1445 | 42 | 11 | int:EED |
| Interaction | BET1 interactions | 1.37e-04 | 385 | 42 | 6 | int:BET1 | |
| Interaction | SF3B3 interactions | 1.40e-04 | 558 | 42 | 7 | int:SF3B3 | |
| Interaction | CHD3 interactions | 1.45e-04 | 757 | 42 | 8 | int:CHD3 | |
| Interaction | BIN1 interactions | 1.49e-04 | 129 | 42 | 4 | int:BIN1 | |
| Interaction | NAA40 interactions | 1.51e-04 | 978 | 42 | 9 | int:NAA40 | |
| Interaction | GJA1 interactions | 1.83e-04 | 583 | 42 | 7 | int:GJA1 | |
| Interaction | SUMO2 interactions | 1.99e-04 | 591 | 42 | 7 | int:SUMO2 | |
| Interaction | RAB9A interactions | 2.07e-04 | 595 | 42 | 7 | int:RAB9A | |
| Interaction | EXOC1 interactions | 2.21e-04 | 143 | 42 | 4 | int:EXOC1 | |
| Interaction | RAB11A interactions | 2.72e-04 | 830 | 42 | 8 | int:RAB11A | |
| Interaction | PXMP2 interactions | 2.84e-04 | 281 | 42 | 5 | int:PXMP2 | |
| Interaction | HDAC11 interactions | 2.93e-04 | 154 | 42 | 4 | int:HDAC11 | |
| Interaction | RPA4 interactions | 3.26e-04 | 452 | 42 | 6 | int:RPA4 | |
| Interaction | GJD3 interactions | 3.34e-04 | 454 | 42 | 6 | int:GJD3 | |
| Interaction | IFI27L1 interactions | 3.36e-04 | 65 | 42 | 3 | int:IFI27L1 | |
| Interaction | KCNA3 interactions | 3.76e-04 | 871 | 42 | 8 | int:KCNA3 | |
| Interaction | EBAG9 interactions | 4.01e-04 | 303 | 42 | 5 | int:EBAG9 | |
| Interaction | NUP155 interactions | 4.34e-04 | 477 | 42 | 6 | int:NUP155 | |
| Interaction | H3C1 interactions | 4.72e-04 | 901 | 42 | 8 | int:H3C1 | |
| Interaction | OBSL1 interactions | 4.75e-04 | 902 | 42 | 8 | int:OBSL1 | |
| Cytoband | Xq27.3 | 5.33e-04 | 37 | 42 | 2 | Xq27.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq27 | 3.18e-03 | 91 | 42 | 2 | chrXq27 | |
| GeneFamily | Ankyrin repeat domain containing | 1.04e-04 | 242 | 19 | 4 | 403 | |
| GeneFamily | Myosin heavy chains | 1.09e-04 | 15 | 19 | 2 | 1098 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SLU7 BPTF CTTNBP2 RESF1 JAKMIP2 TRIP11 CLIP1 GOLGA4 GOLGB1 SYNE2 NOC3L | 3.55e-09 | 656 | 41 | 11 | M18979 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.19e-05 | 90 | 41 | 4 | M39250 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 4.20e-05 | 43 | 41 | 3 | MM666 | |
| Coexpression | ULE_SPLICING_VIA_NOVA2 | 4.20e-05 | 43 | 41 | 3 | M1551 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 4.60e-05 | 856 | 41 | 8 | M4500 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 8.52e-05 | 289 | 41 | 5 | M2196 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | 9.26e-05 | 946 | 41 | 8 | M39169 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP | 2.47e-04 | 196 | 41 | 4 | M5313 | |
| Coexpression | GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN | 2.57e-04 | 198 | 41 | 4 | M9396 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_DN | 2.62e-04 | 199 | 41 | 4 | M3585 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN | 2.67e-04 | 200 | 41 | 4 | M4589 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP | 2.67e-04 | 200 | 41 | 4 | M8860 | |
| Coexpression | GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_DN | 2.67e-04 | 200 | 41 | 4 | M9741 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP | 2.67e-04 | 200 | 41 | 4 | M9736 | |
| Coexpression | GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP | 2.67e-04 | 200 | 41 | 4 | M8203 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.58e-06 | 595 | 41 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.98e-06 | 311 | 41 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.28e-05 | 629 | 41 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.30e-05 | 192 | 41 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 3.30e-05 | 192 | 41 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 9.06e-05 | 989 | 41 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.48e-04 | 139 | 41 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.61e-04 | 298 | 41 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | 3.39e-04 | 492 | 41 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.67e-13 | 199 | 41 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.07e-11 | 199 | 41 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.07e-11 | 199 | 41 | 8 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.07e-11 | 199 | 41 | 8 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.07e-11 | 199 | 41 | 8 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.69e-10 | 198 | 41 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 5.90e-10 | 199 | 41 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.90e-10 | 199 | 41 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 6.11e-10 | 200 | 41 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-08 | 187 | 41 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.74e-08 | 199 | 41 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.83e-08 | 200 | 41 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.73e-07 | 138 | 41 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.44e-07 | 190 | 41 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.06e-06 | 199 | 41 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.09e-06 | 200 | 41 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.83e-05 | 171 | 41 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 178 | 41 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 180 | 41 | 4 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-05 | 184 | 41 | 4 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-05 | 184 | 41 | 4 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-05 | 184 | 41 | 4 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 184 | 41 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.49e-05 | 185 | 41 | 4 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 188 | 41 | 4 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 189 | 41 | 4 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 191 | 41 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 191 | 41 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 191 | 41 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 192 | 41 | 4 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 41 | 4 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 41 | 4 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.06e-05 | 195 | 41 | 4 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.06e-05 | 195 | 41 | 4 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.06e-05 | 195 | 41 | 4 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.06e-05 | 195 | 41 | 4 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 195 | 41 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 195 | 41 | 4 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-05 | 197 | 41 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4|Liver / Manually curated celltypes from each tissue | 3.18e-05 | 197 | 41 | 4 | 4891111894b741555f549deec6af8006376d9358 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.31e-05 | 199 | 41 | 4 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 200 | 41 | 4 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.37e-05 | 200 | 41 | 4 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 200 | 41 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.59e-04 | 135 | 41 | 3 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.59e-04 | 135 | 41 | 3 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 3.60e-04 | 151 | 41 | 3 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.74e-04 | 153 | 41 | 3 | 7518187a5fbf6c0881182dc79bd37c2d49f92b2e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-04 | 153 | 41 | 3 | 93d36723f01c2df39feebf20f3eba5b4fb4cdf59 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.96e-04 | 156 | 41 | 3 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.18e-04 | 159 | 41 | 3 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-04 | 159 | 41 | 3 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-04 | 159 | 41 | 3 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.26e-04 | 160 | 41 | 3 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.26e-04 | 160 | 41 | 3 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.50e-04 | 163 | 41 | 3 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-04 | 166 | 41 | 3 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 4.91e-04 | 168 | 41 | 3 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Control-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 4.91e-04 | 168 | 41 | 3 | d7118d39253ed9790908b850088ebfc5a86f4065 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.91e-04 | 168 | 41 | 3 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.08e-04 | 170 | 41 | 3 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.08e-04 | 170 | 41 | 3 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 5.08e-04 | 170 | 41 | 3 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.17e-04 | 171 | 41 | 3 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 5.26e-04 | 172 | 41 | 3 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | Tuft-tuft-4|World / Class top | 5.44e-04 | 174 | 41 | 3 | d6f306ebf66061bf9e9742000bfedce12d277452 | |
| ToppCell | Healthy_donor-Treg|World / disease group, cell group and cell class (v2) | 5.44e-04 | 174 | 41 | 3 | dc3b06420b0ad9c7060571e7bf5714e028d598bf | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.72e-04 | 177 | 41 | 3 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-04 | 177 | 41 | 3 | 6d89042bda8e244babb68929e84b25edcb545a77 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-04 | 177 | 41 | 3 | daaccf1249dcf816df4caca695a944f53078291a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-04 | 177 | 41 | 3 | c5a16f984c836dbf7d0faf061677844167ab612a | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.72e-04 | 177 | 41 | 3 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-04 | 177 | 41 | 3 | 338bdda26796bf4e16072878c070212d1006cf57 | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.81e-04 | 178 | 41 | 3 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-04 | 179 | 41 | 3 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.00e-04 | 180 | 41 | 3 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-04 | 181 | 41 | 3 | a6c8b33a392de3df2f179317e329e45d3d8c6f52 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 6.10e-04 | 181 | 41 | 3 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | BAL-Control-cDC_8|Control / Compartment, Disease Groups and Clusters | 6.10e-04 | 181 | 41 | 3 | f370161afef2ec827a7b194c06abb9ac1a507cbb | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-04 | 181 | 41 | 3 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.20e-04 | 182 | 41 | 3 | b86690c109cdc16844a6cd2216c1bf2bf28efd45 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.30e-04 | 183 | 41 | 3 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.30e-04 | 183 | 41 | 3 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.30e-04 | 183 | 41 | 3 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.40e-04 | 184 | 41 | 3 | 300edc4aa3ce55f309005c02c315fa0102ea9da7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.40e-04 | 184 | 41 | 3 | 8b397f9c18ed7abecdbcbd586d0ddadf07cf6e75 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue | 6.40e-04 | 184 | 41 | 3 | 22c15ce30171c687ab564f4383ae74d38b759272 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.40e-04 | 184 | 41 | 3 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.50e-04 | 185 | 41 | 3 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.40e-09 | 49 | 26 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.59e-09 | 50 | 26 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.77e-08 | 49 | 26 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.28e-04 | 50 | 26 | 3 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.28e-04 | 50 | 26 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | IL-1 signaling. | 1.04e-03 | 20 | 26 | 2 | MODULE_545 | |
| Drug | Clorgyline | 5.36e-07 | 168 | 41 | 6 | ctd:D003010 | |
| Drug | benzoylphenylalanine | 8.06e-06 | 71 | 41 | 4 | CID000097370 | |
| Drug | Azathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A | 2.62e-05 | 196 | 41 | 5 | 2827_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.68e-05 | 197 | 41 | 5 | 1485_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 2.75e-05 | 198 | 41 | 5 | 1002_UP | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 2.81e-05 | 199 | 41 | 5 | 6765_DN | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 4.98e-04 | 111 | 41 | 3 | EFO_0004530, EFO_0008595 | |
| Disease | FEV/FEC ratio | 1.38e-03 | 1228 | 41 | 7 | EFO_0004713 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.59e-03 | 166 | 41 | 3 | EFO_0004530, EFO_0004611 | |
| Disease | triglycerides in LDL measurement | 2.77e-03 | 56 | 41 | 2 | EFO_0022320 | |
| Disease | optic disc size measurement | 2.90e-03 | 205 | 41 | 3 | EFO_0004832 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.94e-03 | 206 | 41 | 3 | EFO_0004612, EFO_0020947 | |
| Disease | Osteoporosis, Age-Related | 3.27e-03 | 61 | 41 | 2 | C0001787 | |
| Disease | Post-Traumatic Osteoporosis | 3.27e-03 | 61 | 41 | 2 | C0751406 | |
| Disease | Osteoporosis, Senile | 3.27e-03 | 61 | 41 | 2 | C0029459 | |
| Disease | Osteoporosis | 3.49e-03 | 63 | 41 | 2 | C0029456 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.72e-03 | 224 | 41 | 3 | EFO_0004530, EFO_0008317 | |
| Disease | common carotid intimal medial thickness | 3.93e-03 | 67 | 41 | 2 | EFO_0004860 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KHELKMQKLVKAAKD | 341 | O15013 | |
| KKIKELLQMSLEKKE | 161 | Q9NXE8 | |
| YHRLKEKMKKEEADK | 86 | A0A1B0GTR3 | |
| YHRLKEKMKKEEADK | 86 | P0DPH9 | |
| MAHKEIKEKLEGKSK | 231 | Q5JQC9 | |
| EKDKKMLEEKVLNLK | 801 | A2A2Z9 | |
| MERKTFEKEKKIKHE | 836 | Q6UB98 | |
| LKRDLKIKKEKDLMQ | 2771 | Q12830 | |
| EKLKVDKMAHDLEIK | 626 | Q8NB25 | |
| KKSERAKDMHLVKKL | 546 | Q9H2M9 | |
| TELKAKLHEEKMKEL | 71 | Q96AA8 | |
| KILMIKKEHIKKLRE | 351 | Q5TKA1 | |
| EKIKDLHMAEKTKLI | 331 | Q13439 | |
| LIDQHKEFMKKLEEK | 6961 | Q03001 | |
| VKQKLEKEKSELKME | 1216 | P13535 | |
| EASKKEVILLEKMKH | 46 | Q6P3R8 | |
| MESDLELKKDKKHSK | 486 | P35663 | |
| MLKKEKKKAQEALHL | 481 | Q6ZMV9 | |
| EKDKLKMEVDQLKKE | 11 | P63211 | |
| EKHKKEVGKLKSMDL | 946 | Q9H0A0 | |
| KLEDVMAKLEEEKKK | 191 | Q8WZ74 | |
| LNEEKHKELIEKKEM | 146 | Q4G0S7 | |
| KKELERKLSDLEKKM | 1001 | P30622 | |
| DLIKKEEERKKMEKL | 381 | Q9UPQ0 | |
| ERKKKLQEKKMHIAA | 206 | Q8WTT2 | |
| EKSTHEKILEKAMKK | 971 | Q15147 | |
| KNKEGEIHLMKDKAK | 1361 | Q8WXH0 | |
| NVLDMEVKKKKHDKQ | 1381 | Q9HCM1 | |
| EHIDEEKHKKMKLKI | 671 | Q05823 | |
| EKEKMKEKVERILKH | 271 | P78371 | |
| KKMEKLKQKLHTDDE | 156 | Q9Y490 | |
| MDTKKKEEQLKLLKE | 101 | Q9Y3B4 | |
| KKQKEKKHDIMIQEN | 476 | Q06203 | |
| MDKVEDELKEKKKEL | 256 | Q14683 | |
| LMELHQEKLKEEKKK | 486 | O95391 | |
| KMAQKEKEKHEEKLR | 311 | Q13573 | |
| VHELQKLKKKLEMEK | 686 | Q9H6N6 | |
| KLKKKLEMEKEELQV | 691 | Q9H6N6 | |
| KKMEQLEDKIKDINK | 306 | Q15643 | |
| LGKIMDHVKKEKREK | 271 | Q6NUM6 | |
| KMLQKKIEEKDLKVD | 106 | Q9H3S4 | |
| EEKHLKEKKNMQEKL | 2131 | Q14789 | |
| LKHAKDVKDMVSEKK | 5216 | P20929 |